SVF Endurance (Cayman) Ltd

Other

US·SEC (Form 4)

Vir Biotechnology, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€38m

▼ Sales (2 ops.)

Explore the complete record of transactions filed by SVF Endurance (Cayman) Ltd. Director active across 1 companies, notably Vir Biotechnology, Inc.. Aggregated, 2 reports have been recorded. Total volume traded: €37.5m. The latest transaction was filed on 20 December 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Declarations2 total

Executives▼SaleVVir Biotechnology, Inc.◆Signal · 47SEC

S

SVF Endurance (Cayman) Ltd

€19m400,022 shares@ €46.89812.23% mcap100.0% of flow

Common Stock

SEC:0000899243-21-049394·20 Dec 2021

SEC ↗

Executives▼SaleVVir Biotechnology, Inc.43SEC

S

SVF Endurance (Cayman) Ltd

€19m400,022 shares@ €46.89812.23% mcap50.0% of flow